Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [New development lines in immunology. Perspective of pathology].

× No keyword cloud information.

22 in total

1. Micro-immunohistochemistry using a microfluidic probe.

Authors: Robert D Lovchik; Govind V Kaigala; Marios Georgiadis; Emmanuel Delamarche
Journal: Lab Chip Date: 2012-01-12 Impact factor: 6.799

2. A dramatic response to crizotinib in a non-small-cell lung cancer patient with IHC-positive and FISH-negative ALK.

Authors: Jong-Mu Sun; Yoon-La Choi; Jae-Kyung Won; Fred R Hirsch; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park
Journal: J Thorac Oncol Date: 2012-12 Impact factor: 15.609

3. Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin test.

Authors: Josef Rüschoff; Keith M Kerr; Hans J Grote; Peter Middel; Anja von Heydebreck; Venâncio A Alves; Stephan E Baldus; Reinhard Büttner; Lina Carvalho; Ludger Fink; Wolfram Jochum; Anthony W I Lo; Fernando López-Ríos; Alexander Marx; Thierry J Molina; Włodzimierz T Olszewski; Ralf J Rieker; Marco Volante; Erik Thunnissen; Fritz Wrba; Ilhan Celik; Stephan Störkel
Journal: Arch Pathol Lab Med Date: 2012-12-27 Impact factor: 5.534

Review 4. Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice.

Authors: Giulio Rossi; Giuseppe Pelosi; Mattia Barbareschi; Paolo Graziano; Alberto Cavazza; Mauro Papotti
Journal: Int J Surg Pathol Date: 2013-06-05 Impact factor: 1.271

5. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors: Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal: J Clin Oncol Date: 2006-12-11 Impact factor: 44.544

6. Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: a subanalysis of the phase III, randomized SATURN study.

Authors: Yi-Long Wu; Joo-Hang Kim; Keunchil Park; Adel Zaatar; Gaëlle Klingelschmitt; Christina Ng
Journal: Lung Cancer Date: 2012-04-10 Impact factor: 5.705

Review 7. Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment.

Authors: Reinhard Buettner; Jürgen Wolf; Roman K Thomas
Journal: J Clin Oncol Date: 2013-04-15 Impact factor: 44.544

8. HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing.

Authors: Josef Rüschoff; Manfred Dietel; Gustavo Baretton; Susanne Arbogast; Axel Walch; Geneviéve Monges; Marie-Pierre Chenard; Frédérique Penault-Llorca; Iris Nagelmeier; Werner Schlake; H Höfler; H H Kreipe
Journal: Virchows Arch Date: 2010-07-28 Impact factor: 4.064

9. Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma.

Authors: Yong Hannah Wen; Edi Brogi; Adnan Hasanovic; Marc Ladanyi; Robert A Soslow; Dhananjay Chitale; Jinru Shia; Andre L Moreira
Journal: Mod Pathol Date: 2013-04-19 Impact factor: 7.842

10. Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outs.

Authors: Ata Tuna Ciftlik; Hans-Anton Lehr; Martin A M Gijs
Journal: Proc Natl Acad Sci U S A Date: 2013-03-11 Impact factor: 11.205